Chang David D
Reporting Owner SEC Filing List

CIK: 0001611024
FormFilerSubject CompanyFiling AgentDateActions
4Statement of changes in beneficial owner...Allogene Therapeutics, Inc.03/18/2026
4Statement of changes in beneficial owner...Chang David D03/18/2026
4Statement of changes in beneficial owner...Allogene Therapeutics, Inc.02/04/2026
4Statement of changes in beneficial owner...Chang David DAllogene Therapeutics, Inc. /fa02/04/2026
4Statement of changes in beneficial owner...Allogene Therapeutics, Inc.Allogene Therapeutics, Inc. /fa03/18/2025
4Statement of changes in beneficial owner...Chang David DAllogene Therapeutics, Inc. /fa03/18/2025
144Filing for proposed sale of securities u...Allogene Therapeutics, Inc.Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa03/14/2025
144Filing for proposed sale of securities u...Chang David DMerrill Lynch, Pierce, Fenner & Smith Inc/pes/fa03/14/2025
4Statement of changes in beneficial owner...Allogene Therapeutics, Inc.Allogene Therapeutics, Inc. /fa02/05/2025
4Statement of changes in beneficial owner...Chang David DAllogene Therapeutics, Inc. /fa02/05/2025
Load More

Chang David D 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned